Severe infection
Conditions
Interventions
Sponsors
Department of Clinical Pharmacology, Chinese PLA General Hospital, Beijing, China
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Investigator make sure subjects fully understand the trial and the subjects participated in the trial voluntarily and signed the informed consent form or signed by family members; 2. Male or Female, any age; 3. Hospitalized patients,especially Acinetobacter baumannii or Klebsiella pneumoniae infection; 4. Patients were treated with tigecycline alone or in combination.
Exclusion criteria
Exclusion criteria: 1. People who were allergic to tigecycline or hypersensitive; 2. Patients infected by Acinetobacter baumannii or Klebsiella pneumoniae,but did not use tigecycline; Patients who were considered not be candidate for the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood concentration; | — |
Countries
China
Contacts
Public ContactMei He-kun
Department of Clinical Pharmacology, Chinese PLA General Hospital, Beijing, China
Outcome results
None listed